News

Gland Pharma trades higher on the BSE Gland Pharma is currently trading at Rs. 1587.75, up by 6.40 points or 0.40% from its previous closing of Rs. 1581.35 on the BSE. The scrip opened at Rs. 1590.05 and has touched a high and low of Rs. 1627.45 and Rs. 1585.55 respectively. So far 18174 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2606.00 on 02-Sep-2022 and a 52 week low of Rs. 861.50 on 22-May-2023. Last one week high and low of the scrip stood...
Gland Pharma trades higher on the BSE
Gland Pharma trades higher on the BSE
Source: Accord Fintech
24/08/2023 12:20:25 PM
Torrent Pharmaceuticals moves up on getting EIR for Dahej manufacturing facility Torrent Pharmaceuticals is currently trading at Rs. 1950.40, up by 14.95 points or 0.77% from its previous closing of Rs. 1935.05 on the BSE.  The scrip opened at Rs. 1960.05 and has touched a high and low of Rs. 1967.90 and Rs. 1945.10 respectively. So far 2512 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2099.95 on 10-Aug-2023 and a 52 week low of Rs. 1446.15 on 01-Mar-2023. Last one week high and low ...
Torrent Pharmaceuticals moves up on getting EIR for Dahej manufacturing facility
Torrent Pharmaceuticals moves up on getting EIR for Dahej manufacturing facility
Source: Accord Fintech
24/08/2023 10:08:24 AM
Marksans Pharma jumps on getting USFDA`s final approval for Guaifenesin Extended-Release Tablets Marksans Pharma is currently trading at Rs. 112.75, up by 3.05 points or 2.78% from its previous closing of Rs. 109.70 on the BSE. The scrip opened at Rs. 110.00 and has touched a high and low of Rs. 114.75 and Rs. 110.00 respectively. So far 308136 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 122.50 on 10-Aug-2023 and a 52 week low of Rs. 45.65 on 11-Oct-2022. Last one week high and low of the scrip stood at...
Marksans Pharma jumps on getting USFDA`s final approval for Guaifenesin Extended-Release Tablets
Marksans Pharma jumps on getting USFDA`s final approval for Guaifenesin Extended-Release Tablets
Source: Accord Fintech
22/08/2023 3:22:27 PM
Lupin trades higher on receiving USFDA`s approval for Doxycycline Hyclate Delayed-Release Tablets Lupin is currently trading at Rs. 1091.25, up by 9.55 points or 0.88% from its previous closing of Rs. 1081.70 on the BSE. The scrip opened at Rs. 1094.75 and has touched a high and low of Rs. 1094.75 and Rs. 1078.60 respectively. So far 12461 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1108.95 on 09-Aug-2023 and a 52 week low of Rs. 623.20 on 19-Sep-2022. Last one week high and low of the scrip stood at Rs....
Lupin trades higher on receiving USFDA`s approval for Doxycycline Hyclate Delayed-Release Tablets
Lupin trades higher on receiving USFDA`s approval for Doxycycline Hyclate Delayed-Release Tablets
Source: Accord Fintech
16/08/2023 11:29:20 AM
Lupin rises as its Mandideep Unit-2 Facility completes USFDA inspection with No Observations Lupin is currently trading at Rs. 1089.75, up by 12.80 points or 1.19% from its previous closing of Rs. 1076.95 on the BSE. The scrip opened at Rs. 1077.35 and has touched a high and low of Rs. 1105.80 and Rs. 1077.35 respectively. So far 54151 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1108.95 on 09-Aug-2023 and a 52 week low of Rs. 623.20 on 19-Sep-2022. Last one week high and low of the scrip stood at Rs...
Lupin rises as its Mandideep Unit-2 Facility completes USFDA inspection with No Observations
Lupin rises as its Mandideep Unit-2 Facility completes USFDA inspection with No Observations
Source: Nirmal Bang Ltd
14/08/2023 11:09:52 AM
Glenmark Pharmaceuticals gains on getting USFDA`s final approval for Saxagliptin Tablets Glenmark Pharmaceuticals is currently trading at Rs. 794.40, up by 6.20 points or 0.79% from its previous closing of Rs. 788.20 on the BSE. The scrip opened at Rs. 799.55 and has touched a high and low of Rs. 799.55 and Rs. 790.00 respectively. So far 3085 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 832.90 on 27-Jul-2023 and a 52 week low of Rs. 361.70 on 29-Aug-2022. Last one week high and low of the scrip ...
Glenmark Pharmaceuticals gains on getting USFDA`s final approval for Saxagliptin Tablets
Glenmark Pharmaceuticals gains on getting USFDA`s final approval for Saxagliptin Tablets
Source: Accord Fintech
1/08/2023 10:17:50 AM
Lupin rises on getting tentative approval for Dolutegravir Lamivudine & Tenofovir Alafenamide Tablets Lupin is currently trading at Rs. 938.60, up by 3.75 points or 0.40% from its previous closing of Rs. 934.85 on the BSE. The scrip opened at Rs. 943.95 and has touched a high and low of Rs. 945.00 and Rs. 937.80 respectively. So far 7417 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 947.95 on 21-Jul-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at Rs. 947.95...
Lupin rises on getting tentative approval for Dolutegravir Lamivudine & Tenofovir Alafenamide Tablets
Lupin rises on getting tentative approval for Dolutegravir Lamivudine & Tenofovir Alafenamide Tablets
Source: Accord Fintech
24/07/2023 12:20:10 PM
Marksans Pharma zooms on getting USFDA`s final approval for Acetaminophen and Ibuprofen Tablets Marksans Pharma is currently trading at Rs. 101.18, up by 7.77 points or 8.32% from its previous closing of Rs. 93.41 on the BSE. The scrip opened at Rs. 93.42 and has touched a high and low of Rs. 102.90 and Rs. 93.42 respectively. So far 530856 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 102.90 on 12-Jul-2023 and a 52 week low of Rs. 45.65 on 11-Oct-2022. Last one week high and low of the scrip stood at Rs...
Marksans Pharma zooms on getting USFDA`s final approval for Acetaminophen and Ibuprofen Tablets
Marksans Pharma zooms on getting USFDA`s final approval for Acetaminophen and Ibuprofen Tablets
Source: Accord Fintech
12/07/2023 12:29:37 PM
Lupin gains on receiving EIR from USFDA for Pithampur Unit-2 Manufacturing Facility Lupin is currently trading at Rs. 920.00, up by 7.10 points or 0.78% from its previous closing of Rs. 912.90 on the BSE. The scrip opened at Rs. 928.00 and has touched a high and low of Rs. 934.90 and Rs. 915.60 respectively. So far 11476 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 934.90 on 12-Jul-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at Rs. 934.9...
Lupin gains on receiving EIR from USFDA for Pithampur Unit-2 Manufacturing Facility
Lupin gains on receiving EIR from USFDA for Pithampur Unit-2 Manufacturing Facility
Source: accourd fintech
12/07/2023 10:08:19 AM
Zydus Lifesciences rises on getting USFDA`s final nod for Oxcarbazepine Tablets Zydus Lifesciences rises on getting USFDA’s final nod for Oxcarbazepine Tablets Jul-05-2023   14:06 Hrs IST Zydus Lifesciences is currently trading at Rs. 582.10, up by 7.80 points or 1.36% from its previous closing of Rs. 574.30 on the BSE. The scrip opened at Rs. 574.85 and has touched a high and low of Rs. 583.25 and Rs. 573.90 respectively. So far 23649 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week ...
Zydus Lifesciences rises on getting USFDA`s final nod for Oxcarbazepine Tablets
Zydus Lifesciences rises on getting USFDA`s final nod for Oxcarbazepine Tablets
Source: Accord Fintech
5/07/2023 2:18:38 PM
Lupin moves up on getting approval from USFDA for Cyanocobalamin Nasal Spray Lupin is currently trading at Rs. 898.00, up by 5.55 points or 0.62% from its previous closing of Rs. 892.45 on the BSE. The scrip opened at Rs. 885.55 and has touched a high and low of Rs. 902.00 and Rs. 885.55 respectively. So far 10866 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 908.65 on 30-Jun-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at Rs. 908.6...
Lupin moves up on getting approval from USFDA for Cyanocobalamin Nasal Spray
Lupin moves up on getting approval from USFDA for Cyanocobalamin Nasal Spray
Source: Accord Fintech
4/07/2023 10:49:24 AM
Zydus Lifesciences inches up on getting tentative nod from USFDA for Palbociclib Tablets Zydus Lifesciences is currently trading at Rs. 584.20, up by 2.15 points or 0.37% from its previous closing of Rs. 582.05 on the BSE. The scrip opened at Rs. 586.05 and has touched a high and low of Rs. 587.45 and Rs. 581.30 respectively. So far 4495 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 588.85 on 28-Jun-2023 and a 52 week low of Rs. 338.00 on 26-Jul-2022. Last one week high and low of the scrip stood ...
Zydus Lifesciences inches up on getting tentative nod from USFDA for Palbociclib Tablets
Zydus Lifesciences inches up on getting tentative nod from USFDA for Palbociclib Tablets
Source: Accord Fintech
30/06/2023 10:07:06 AM
Granules India gains after USFDA completes surveillance inspection at Jeedimetla facility with zero observations Granules India is currently trading at Rs. 288.75, up by 1.20 points or 0.42% from its previous closing of Rs. 287.55 on the BSE. The scrip opened at Rs. 287.55 and has touched a high and low of Rs. 290.50 and Rs. 281.40 respectively. So far 56630 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 381.25 on 04-Nov-2022 and a 52 week low of Rs. 238.05 on 23-Jun-2022. Last one week high and low of the scrip stood at ...
Granules India gains after USFDA completes surveillance inspection at Jeedimetla facility with zero observations
Granules India gains after USFDA completes surveillance inspection at Jeedimetla facility with zero observations
Source: Accord Fintech
23/06/2023 4:10:36 PM
Glenmark Pharmaceuticals falls after USFDA issues warning letter to Monroe facility Glenmark Pharmaceuticals is currently trading at Rs. 625.05, down by 17.65 points or 2.75% from its previous closing of Rs. 642.70 on the BSE. The scrip opened at Rs. 637.10 and has touched a high and low of Rs. 641.00 and Rs. 622.05 respectively. So far 24274 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 682.00 on 08-Jun-2023 and a 52 week low of Rs. 351.40 on 23-Jun-2022. Last one week high and low of the sc...
Glenmark Pharmaceuticals falls after USFDA issues warning letter to Monroe facility
Glenmark Pharmaceuticals falls after USFDA issues warning letter to Monroe facility
Source: Accord Fintech
22/06/2023 2:25:22 PM
Lupin zooms on getting USFDA`s approval for Tiotropium Bromide Inhalation Powder. Lupin is currently trading at Rs. 875.00, up by 45.35 points or 5.47% from its previous closing of Rs. 829.65 on the BSE. The scrip opened at Rs. 834.95 and has touched a high and low of Rs. 885.00 and Rs. 829.25 respectively. So far 174889 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 885.00 on 21-Jun-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022. Last one week high and low of the scrip stood at Rs. 885...
Lupin zooms on getting USFDA`s approval for Tiotropium Bromide Inhalation Powder.
Lupin zooms on getting USFDA`s approval for Tiotropium Bromide Inhalation Powder.
Source: Accord Fintech
21/06/2023 3:33:37 PM
Zydus Lifesciences gains on getting USFDA`s final nod for Minocycline Hydrochloride Extended-Release tablets Zydus Lifesciences is currently trading at Rs. 556.30, up by 1.95 points or 0.35% from its previous closing of Rs. 554.35 on the BSE. The scrip opened at Rs. 556.00 and has touched a high and low of Rs. 558.00 and Rs. 553.80 respectively. So far 16064 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 562.15 on 19-Jun-2023 and a 52 week low of Rs. 329.60 on 20-Jun-2022. Last one week high and low of the scrip stood...
Zydus Lifesciences gains on getting USFDA`s final nod for Minocycline Hydrochloride Extended-Release tablets
Zydus Lifesciences gains on getting USFDA`s final nod for Minocycline Hydrochloride Extended-Release tablets
Source: Accord Fintech
20/06/2023 10:46:26 AM
Lupin gains on launching Thiamine Hydrochloride Injection in United States Lupin is currently trading at Rs. 832.50, up by 1.65 points or 0.20% from its previous closing of Rs. 830.85 on the BSE. The scrip opened at Rs. 821.00 and has touched a high and low of Rs. 833.85 and Rs. 821.00 respectively. So far 11156 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 843.40 on 16-Jun-2023 and a 52 week low of Rs. 592.55 on 17-Jun-2022. Last one week high and low of the scrip stood at Rs. 843.4...
Lupin gains on launching Thiamine Hydrochloride Injection in United States
Lupin gains on launching Thiamine Hydrochloride Injection in United States
Source: Accord Fintech
19/06/2023 12:25:32 PM
Torrent Pharmaceuticals rises on getting EIR for Gujarat Oral-Oncology manufacturing facility Torrent Pharmaceuticals is currently trading at Rs. 1848.30, up by 7.30 points or 0.40% from its previous closing of Rs. 1841.00 on the BSE. The scrip opened at Rs. 1880.00 and has touched a high and low of Rs. 1880.00 and Rs. 1840.70 respectively. So far 10198 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1886.25 on 31-May-2023 and a 52 week low of Rs. 1361.03 on 20-Jun-2022. Last one week high and low of the...
Torrent Pharmaceuticals rises on getting EIR for Gujarat Oral-Oncology manufacturing facility
Torrent Pharmaceuticals rises on getting EIR for Gujarat Oral-Oncology manufacturing facility
Source: Accord Fintech
16/06/2023 12:52:16 PM
Laurus Labs moves up on getting EIR from USFDA for Andhra Pradesh manufacturing facility Laurus Labs is currently trading at Rs. 368.95, up by 2.15 points or 0.59% from its previous closing of Rs. 366.80 on the BSE. The scrip opened at Rs. 368.95 and has touched a high and low of Rs. 371.45 and Rs. 366.80 respectively. So far 34287 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 605.50 on 18-Aug-2022 and a 52 week low of Rs. 279.65 on 28-Apr-2023. Last one week high and low of the scrip stood at Rs....
Laurus Labs moves up on getting EIR from USFDA for Andhra Pradesh manufacturing facility
Laurus Labs moves up on getting EIR from USFDA for Andhra Pradesh manufacturing facility
Source: Accord Fintech
16/06/2023 10:40:40 AM
Granules India gains on getting USFDA`s approval for Levetiracetam Tablets Granules India is currently trading at Rs. 288.30, up by 2.75 points or 0.96% from its previous closing of Rs. 285.55 on the BSE. The scrip opened at Rs. 285.75 and has touched a high and low of Rs. 289.00 and Rs. 285.75 respectively. So far 38097 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 381.25 on 04-Nov-2022 and a 52 week low of Rs. 227.00 on 20-Jun-2022. Last one week high and low of the scrip stood at ...
Granules India gains on getting USFDA`s approval for Levetiracetam Tablets
Granules India gains on getting USFDA`s approval for Levetiracetam Tablets
Source: Accord Fintech
14/06/2023 11:36:21 AM
Zydus Lifesciences gains on getting USFDA`s final nod for Diclofenac Sodium and Misoprostol Delayed Release tablets Zydus Lifesciences is currently trading at Rs. 520.35, up by 2.65 points or 0.51% from its previous closing of Rs. 517.70 on the BSE. The scrip opened at Rs. 522.60 and has touched a high and low of Rs. 523.15 and Rs. 515.85 respectively. So far 29575 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 530.70 on 09-May-2023 and a 52 week low of Rs. 329.60 on 20-Jun-2022. Last one week high and low of the scrip stood...
Zydus Lifesciences gains on getting USFDA`s final nod for Diclofenac Sodium and Misoprostol Delayed Release tablets
Zydus Lifesciences gains on getting USFDA`s final nod for Diclofenac Sodium and Misoprostol Delayed Release tablets
Source: Accord Fintech
14/06/2023 11:03:42 AM
Granules India jumps on getting USFDA`s approval for Metoprolol Succinate ER Tablets Granules India is currently trading at Rs. 284.45, up by 5.20 points or 1.86% from its previous closing of Rs. 279.25 on the BSE. The scrip opened at Rs. 280.50 and has touched a high and low of Rs. 285.00 and Rs. 279.70 respectively. So far 18691 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 381.25 on 04-Nov-2022 and a 52 week low of Rs. 227.00 on 20-Jun-2022. Last one week high and low of the scrip stood at ...
Granules India jumps on getting USFDA`s approval for Metoprolol Succinate ER Tablets
Granules India jumps on getting USFDA`s approval for Metoprolol Succinate ER Tablets
Source: Accord Fintech
13/06/2023 12:22:12 PM
Caplin Point Laboratories surges after its arm gets USFDA`s approval for Cisatracurium Besylate Injection Caplin Point Laboratories is currently trading at Rs. 812.00, up by 11.70 points or 1.46% from its previous closing of Rs. 800.30 on the BSE. The scrip opened at Rs. 800.00 and has touched a high and low of Rs. 815.05 and Rs. 791.10 respectively. So far 18589 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 856.00 on 02-Aug-2022 and a 52 week low of Rs. 575.00 on 29-Mar-2023. Last one week high and low of the scr...
Caplin Point Laboratories surges after its arm gets USFDA`s approval for Cisatracurium Besylate Injection
Caplin Point Laboratories surges after its arm gets USFDA`s approval for Cisatracurium Besylate Injection
Source: Accord Fintech
12/06/2023 4:08:49 PM
Lupin rises on getting USFDA`s approval for Obeticholic Acid Tablets Lupin is currently trading at Rs. 812.90, up by 8.35 points or 1.04% from its previous closing of Rs. 804.55 on the BSE. The scrip opened at Rs. 800.05 and has touched a high and low of Rs. 816.90 and Rs. 800.05 respectively. So far 3322 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 816.90 on 1-June-2023 and a 52 week low of Rs. 592.55 on 17-Jun-2022. Last one week high and low of the scrip stood at Rs. 816.90...
Lupin rises on getting USFDA`s approval for Obeticholic Acid Tablets
Lupin rises on getting USFDA`s approval for Obeticholic Acid Tablets
Source: Accord Fintech
1/06/2023 9:53:59 AM
Granules India rises on getting USFDA`s approval for Venlafaxine Hydrochloride Capsules Granules India is currently trading at Rs. 278.85, up by 1.20 points or 0.43% from its previous closing of Rs. 277.65 on the BSE. The scrip opened at Rs. 278.70 and has touched a high and low of Rs. 283.00 and Rs. 274.25 respectively. So far 26185 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 381.25 on 04-Nov-2022 and a 52 week low of Rs. 227.00 on 20-Jun-2022. Last one week high and low of the scrip stood at ...
Granules India rises on getting USFDA`s approval for Venlafaxine Hydrochloride Capsules
Granules India rises on getting USFDA`s approval for Venlafaxine Hydrochloride Capsules
Source: Accord Fintech
19/05/2023 11:37:08 AM
Strides Pharma Science shines on getting EIR from USFDA for Puducherry manufacturing facility Strides Pharma Science is currently trading at Rs. 366.50, up by 7.10 points or 1.98% from its previous closing of Rs. 359.40 on the BSE. The scrip opened at Rs. 364.85 and has touched a high and low of Rs. 375.00 and Rs. 363.30 respectively. So far 5955 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 392.20 on 22-Dec-2022 and a 52 week low of Rs. 268.40 on 21-Mar-2023. Last one week high and low of the scrip s...
Strides Pharma Science shines on getting EIR from USFDA for Puducherry manufacturing facility
Strides Pharma Science shines on getting EIR from USFDA for Puducherry manufacturing facility
Source: Accord Fintech
19/05/2023 9:48:32 AM
Alembic Pharmaceuticals surges on getting EIR for Solid Oral Formulation Facility at Vadodara Alembic Pharmaceuticals is currently trading at Rs. 574.85, up by 3.10 points or 0.54% from its previous closing of Rs. 571.75 on the BSE. The scrip opened at Rs. 573.85 and has touched a high and low of Rs. 582.85 and Rs. 563.65 respectively. So far 3516 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 775.00 on 24-May-2022 and a 52 week low of Rs. 463.30 on 29-Mar-2023. Last one week high and low of the scrip s...
Alembic Pharmaceuticals surges on getting EIR for Solid Oral Formulation Facility at Vadodara
Alembic Pharmaceuticals surges on getting EIR for Solid Oral Formulation Facility at Vadodara
Source: Accord Fintech
10/05/2023 3:39:11 PM
Zydus Lifesciences rises on getting final nod for Icosapent Ethyl Capsules from USFDA Zydus Lifesciences is currently trading at Rs. 522.75, up by 5.45 points or 1.05% from its previous closing of Rs. 517.30 on the BSE. The scrip opened at Rs. 517.30 and has touched a high and low of Rs. 524.35 and Rs. 516.00 respectively. So far 7326 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 524.35 on 24-Apr-2023 and a 52 week low of Rs. 319.40 on 11-May-2022. Last one week high and low of the scrip stood ...
Zydus Lifesciences rises on getting final nod for Icosapent Ethyl Capsules from USFDA
Zydus Lifesciences rises on getting final nod for Icosapent Ethyl Capsules from USFDA
Source: Accord Fintech
24/04/2023 9:57:01 AM
Zydus Lifesciences inches up on getting USFDA`s final approval for Estradiol Transdermal System Zydus Lifesciences is currently trading at Rs. 517.10, up by 1.35 points or 0.26% from its previous closing of Rs. 515.75 on the BSE. The scrip opened at Rs. 519.70 and has touched a high and low of Rs. 519.70 and Rs. 514.50 respectively. So far 4781 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 519.70  on 19-Apr-2023 and a 52 week low of Rs. 319.40 on 11-May-2022. Last one week high and low of the scrip ...
Zydus Lifesciences inches up on getting USFDA`s final approval for Estradiol Transdermal System
Zydus Lifesciences inches up on getting USFDA`s final approval for Estradiol Transdermal System
Source: Accord Fintech
19/04/2023 9:46:30 AM
Zydus Lifesciences rises on getting USFDA`s final approval for Isoproterenol Hydrochloride Injection Zydus Lifesciences is currently trading at Rs. 507.55, up by 3.90 points or 0.77% from its previous closing of Rs. 503.65 on the BSE. The scrip opened at Rs. 505.05 and has touched a high and low of Rs. 508.20 and Rs. 504.45 respectively. So far 2971 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 508.20 on 17-Apr-2023 and a 52 week low of Rs. 319.40 on 11-May-2022. Last one week high and low of the scrip stood ...
Zydus Lifesciences rises on getting USFDA`s final approval for Isoproterenol Hydrochloride Injection
Zydus Lifesciences rises on getting USFDA`s final approval for Isoproterenol Hydrochloride Injection
Source: IANS
17/04/2023 9:41:54 AM
Zydus Lifesciences hits 52 week high on getting USFDA`s final approval for Tavaborole Topical Solution Zydus Lifesciences is currently trading at Rs. 503.50, up by 2.70 points or 0.54% from its previous closing of Rs. 500.80 on the BSE. The scrip opened at Rs. 500.05 and has touched a high and low of Rs. 503.50 and Rs. 498.50 respectively. So far 15706 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 503.50 on 12-Apr-2023 and a 52 week low of Rs. 319.40 on 11-May-2022. Last one week high and low of the scrip stood...
Zydus Lifesciences hits 52 week high on getting USFDA`s final approval for Tavaborole Topical Solution
Zydus Lifesciences hits 52 week high on getting USFDA`s final approval for Tavaborole Topical Solution
Source: Accord Fintech
12/04/2023 11:32:38 AM
Zydus Lifesciences gains on getting USFDA`s final approval for Azithromycin Tablets Zydus Lifesciences is currently trading at Rs. 497.65, up by 1.15 points or 0.23% from its previous closing of Rs. 496.50 on the BSE. The scrip opened at Rs. 499.65 and has touched a high and low of Rs. 501.35 and Rs. 493.60 respectively. So far 39687 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 501.35 on 11-Apr-2023 and a 52 week low of Rs. 319.40 on 11-May-2022. Last one week high and low of the scrip stood...
Zydus Lifesciences gains on getting USFDA`s final approval for Azithromycin Tablets
Zydus Lifesciences gains on getting USFDA`s final approval for Azithromycin Tablets
Source: Accord Fintech
11/04/2023 2:40:37 PM
Shilpa Medicare zooms on getting USFDA`s final nod for Apremilast Tablets Shilpa Medicare is currently trading at Rs. 256.15, up by 22.95 points or 9.84% from its previous closing of Rs. 233.20 on the BSE. The scrip opened at Rs. 246.00 and has touched a high and low of Rs. 259.00 and Rs. 246.00 respectively. So far 79446 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 503.05 on 13-Apr-2022 and a 52 week low of Rs. 222.40 on 28-Mar-2023. Last one week high and low of the scrip stood a...
Shilpa Medicare zooms on getting USFDA`s final nod for Apremilast Tablets
Shilpa Medicare zooms on getting USFDA`s final nod for Apremilast Tablets
Source: Accord Fintech
11/04/2023 9:57:02 AM
Zydus Lifesciences gains on getting USFDA`s final approval for Levothyroxine Sodium for Injection Zydus Lifesciences is currently trading at Rs 483.25, up by 0.95 points or 0.20% from its previous closing of Rs. 482.30 on the BSE. The scrip opened at Rs. 478.60 and has touched a high and low of Rs. 483.05 and Rs. 478.45 respectively. So far 10146 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 488.10 on 16-Mar-2023 and a 52 week low of Rs. 319.40 on 11-May-2022. Last one week high and low of the scrip stood ...
Zydus Lifesciences gains on getting USFDA`s final approval for Levothyroxine Sodium for Injection
Zydus Lifesciences gains on getting USFDA`s final approval for Levothyroxine Sodium for Injection
Source: Accord Fintech
28/03/2023 11:10:58 AM
Lupin zooms on getting USFDA`s tentative approval for Valbenazine Capsules Lupin zooms on getting USFDA’s tentative approval for Valbenazine Capsules Mar-27-2023   11:05 Hrs IST Lupin is currently trading at Rs. 668.70, up by 28.95 points or 4.53% from its previous closing of Rs. 639.75 on the BSE. The scrip opened at Rs. 645.00 and has touched a high and low of Rs. 669.00 and Rs. 642.25 respectively. So far 33583 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 798.9...
Lupin zooms on getting USFDA`s tentative approval for Valbenazine Capsules
Lupin zooms on getting USFDA`s tentative approval for Valbenazine Capsules
Source: Accord Fintech
27/03/2023 11:45:38 AM
Lupin moves up on getting USFDA`s tentative approval for Obeticholic Acid Tablets Lupin is currently trading at Rs. 652.00, up by 3.50 points or 0.54% from its previous closing of Rs. 648.50 on the BSE. The scrip opened at Rs. 654.95 and has touched a high and low of Rs. 654.95 and Rs. 646.75 respectively. So far 6037 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 798.90 on 05-Apr-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 665.65...
Lupin moves up on getting USFDA`s tentative approval for Obeticholic Acid Tablets
Lupin moves up on getting USFDA`s tentative approval for Obeticholic Acid Tablets
Source: Accord Fintech
24/03/2023 10:55:39 AM
Zydus Lifesciences surges after its arm gets USFDA`s approval for Tofacitinib Tablets Zydus Lifesciences is currently trading at Rs. 483.20, up by 4.65 points or 0.97% from its previous closing of Rs. 478.55 on the BSE. The scrip opened at Rs. 478.60 and has touched a high and low of Rs. 484.50 and Rs. 478.20 respectively. So far 32866 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 488.10 on 16-Mar-2023 and a 52 week low of Rs. 319.40 on 11-May-2022. Last one week high and low of the scrip stood...
Zydus Lifesciences surges after its arm gets USFDA`s approval for Tofacitinib Tablets
Zydus Lifesciences surges after its arm gets USFDA`s approval for Tofacitinib Tablets
Source: Accord Fintech
23/03/2023 4:39:30 PM
Lupin inches up as its alliance partner gets USFDA`s final approval for Rocuronium Bromide Injection Lupin is currently trading at Rs. 648.10, up by 1.90 points or 0.29% from its previous closing of Rs. 646.20 on the BSE. The scrip opened at Rs. 657.00 and has touched a high and low of Rs. 657.00 and Rs. 646.80 respectively. So far 1627 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 798.90 on 05-Apr-2022 and a 52 week low of Rs. 583.05 on 25-May-2022. Last one week high and low of the scrip stood at Rs. 668.80...
Lupin inches up as its alliance partner gets USFDA`s final approval for Rocuronium Bromide Injection
Lupin inches up as its alliance partner gets USFDA`s final approval for Rocuronium Bromide Injection
Source: ACCCORD FINTECH
21/03/2023 9:47:22 AM
Zydus Lifesciences inches up on getting USFDA`s final approval for Lenalidomide Capsules Zydus Lifesciences is currently trading at Rs. 477.80, up by 1.80 points or 0.38% from its previous closing of Rs. 476.00 on the BSE. The scrip opened at Rs. 474.05 and has touched a high and low of Rs. 478.25 and Rs. 473.05 respectively. So far 3309 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 482.20 on 08-Feb-2023 and a 52 week low of Rs. 319.40 on 11-May-2022. Last one week high and low of the scrip stood ...
Zydus Lifesciences inches up on getting USFDA`s final approval for Lenalidomide Capsules
Zydus Lifesciences inches up on getting USFDA`s final approval for Lenalidomide Capsules
Source: Accord Fintech
8/03/2023 10:12:46 AM
Caplin Point Laboratories gains as its arm gets USFDA’s approval for Rocuronium Bromide Injection Caplin Point Laboratories is currently trading at Rs. 665.00, up by 9.45 points or 1.44% from its previous closing of Rs. 655.55 on the BSE. The scrip opened at Rs. 648.15 and has touched a high and low of Rs. 673.55 and Rs. 648.15 respectively. So far 1960 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 856.00 on 02-Aug-2022 and a 52 week low of Rs. 626.30 on 11-May-2022. Last one week high and low of the scrip...
Caplin Point Laboratories gains as its arm gets USFDA’s approval for Rocuronium Bromide Injection
Caplin Point Laboratories gains as its arm gets USFDA’s approval for Rocuronium Bromide Injection
Source: Accord Fintech
3/03/2023 2:32:41 PM
Zydus Lifesciences trades higher on getting USFDAs approval for Apixaban Tablets Zydus Lifesciences is currently trading at Rs. 469.30, up by 3.75 points or 0.81% from its previous closing of Rs. 465.55 on the BSE. The scrip opened at Rs. 469.95 and has touched a high and low of Rs. 472.00 and Rs. 463.35 respectively. So far 6591 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 482.20 on 08-Feb-2023 and a 52 week low of Rs. 319.40 on 11-May-2022. Last one week high and low of the scrip stood ...
Zydus Lifesciences trades higher on getting USFDAs approval for Apixaban Tablets
Zydus Lifesciences trades higher on getting USFDAs approval for Apixaban Tablets
Source: Accord Fintech
1/03/2023 10:43:23 AM
Hyderabad home to maximum USFDA approved pharma units in world Hyderabad, which has emerged as a key global hub in life sciences, is home to the largest number of US Food and Drug Administration (USFDA) approved companies in the world. With 214 units certified by the US drug administrator, Hyderabad is far ahead of New Jersey, which stands second with 189 USFDA approved units, Telangana Industries, Commerce and Information Technology Minister K.T. Rama Rao said on Tuesday. He said the state government would make efforts for setting up of USFDA offi...
Hyderabad home to maximum USFDA approved pharma units in world
Hyderabad home to maximum USFDA approved pharma units in world
Source: IANS
22/02/2023 9:13:19 AM
Dishman Carbogen Amcis moves up as its arm completes USFDA`s inspection at Switzerland manufacturing site Dishman Carbogen Amcis is currently trading at Rs. 103.30, up by 1.90 points or 1.87 % from its previous closing of Rs. 101.40 on the BSE. The scrip opened at Rs. 101.55 and has touched a high and low of Rs. 104.90 and Rs. 100.65 respectively. So far 78850 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 201.35 on 05-Apr-2022 and a 52 week low of Rs. 80.05 on 03-Feb-2023. Last one week high and low of the scrip s...
Dishman Carbogen Amcis moves up as its arm completes USFDA`s inspection at Switzerland manufacturing site
Dishman Carbogen Amcis moves up as its arm completes USFDA`s inspection at Switzerland manufacturing site
Source: Accord Fintech
17/02/2023 12:04:17 PM
Sun Pharmaceutical Industries rises on launching SEZABY in U.S. Sun Pharmaceutical Industries is currently trading at Rs. 1044.00, up by 4.05 points or 0.39% from its previous closing of Rs. 1039.95 on the BSE. The scrip opened at Rs. 1040.10 and has touched a high and low of Rs. 1050.10 and Rs. 1034.15 respectively. So far 9079 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1070.80 on 02-Nov-2022 and a 52 week low of Rs. 789.75 on 17-Jun-2022. Last one week high and low of...
Sun Pharmaceutical Industries rises on launching SEZABY in U.S.
Sun Pharmaceutical Industries rises on launching SEZABY in U.S.
Source: Accord Fintech
27/01/2023 11:47:33 AM
Zydus Lifesciences rises as its arm gets USFDA`s final approval to market Brexpiprazole Tablets Zydus Lifesciences is currently trading at Rs. 454.30, up by 2.15 points or 0.48% from its previous closing of Rs. 452.15 on the BSE. The scrip opened at Rs. 452.90 and has touched a high and low of Rs. 457.00 and Rs. 447.50 respectively. So far 17014 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 458.60 on 10-Jan-2023 and a 52 week low of Rs. 319.40 on 11-May-2022. Last one week high and low of the scrip stood...
Zydus Lifesciences rises as its arm gets USFDA`s final approval to market Brexpiprazole Tablets
Zydus Lifesciences rises as its arm gets USFDA`s final approval to market Brexpiprazole Tablets
Source: IANS
12/01/2023 11:19:06 AM
Alembic Pharmaceuticals gains on getting nod for Fulvestrant Injection from USFDA Alembic Pharmaceuticals is currently trading at Rs. 587.10, up by 5.50 points or 0.95% from its previous closing of Rs. 581.60 on the BSE. The scrip opened at Rs. 572.05 and has touched a high and low of Rs. 592.65 and Rs. 572.05 respectively. So far 1034 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 847.95 on 04-Jan-2022 and a 52 week low of Rs. 541.10 on 20-Oct-2022. Last one week high and low of the scrip s...
Alembic Pharmaceuticals gains on getting nod for Fulvestrant Injection from USFDA
Alembic Pharmaceuticals gains on getting nod for Fulvestrant Injection from USFDA
Source: Accord Fintech
26/12/2022 9:58:29 AM
Alembic Pharmaceuticals surges on getting USFDA`s final approval for Diclofenac Sodium Topical Solution Alembic Pharmaceuticals is currently trading at Rs. 597.95, up by 2.95 points or 0.50% from its previous closing of Rs. 595.00 on the BSE. The scrip opened at Rs. 593.00 and has touched a high and low of Rs. 606.50 and Rs. 593.00 respectively. So far 2940 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 847.95 on 04-Jan-2022 and a 52 week low of Rs. 541.10 on 20-Oct-2022. Last one week high and low of the scrip s...
Alembic Pharmaceuticals surges on getting USFDA`s final approval for Diclofenac Sodium Topical Solution
Alembic Pharmaceuticals surges on getting USFDA`s final approval for Diclofenac Sodium Topical Solution
Source: Accord Fintech
1/12/2022 2:14:45 PM
Zydus Lifesciences inches up as its arm receives USFDA`s approval for Levothyroxine Sodium for Injection Zydus Lifesciences is currently trading at Rs. 402.65, up by 0.85 points or 0.21% from its previous closing of Rs. 401.80 on the BSE. The scrip opened at Rs. 402.10 and has touched a high and low of Rs. 404.80 and Rs. 402.10 respectively. So far 1015 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 487.00 on 03-Jan-2022 and a 52 week low of Rs. 319.40 on 11-May-2022. Last one week high and low of the scrip stood ...
Zydus Lifesciences inches up as its arm receives USFDA`s approval for Levothyroxine Sodium for Injection
Zydus Lifesciences inches up as its arm receives USFDA`s approval for Levothyroxine Sodium for Injection
Source: Accord Fintech
28/11/2022 10:36:28 AM